Enliven Therapeutics (ELVN, $21.56) Moving Average Convergence Divergence (MACD) Histogram turned negative on July 22, 2025

#Biotechnology, #TechnicalAnalysis, #MACD, #Bearish, #Stocks, #SmallCap, #Russel2000
ELVN - Enliven Therapeutics
MACD signal
Bearish Trend
82%
Odds of DOWN Trend
Price: $21.56
Daily change: -$0.31 (-1.42%)
Daily volume: 278.2K
Capitalization: $1.3B
Industry: Biotechnology

This is a Bearish indicator signaling ELVN's price could decline from here. Traders may explore shorting the stock or put options. A.I. dvisor identified 51 similar cases where ELVN's MACD histogram became negative, and 42 of them led to successful outcomes. Odds of Success: 82%.